ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Medipharma Limited

Medipharma Limited is an active company incorporated on 29 October 1991 with the registered office located in Andover, Hampshire. Medipharma Limited was registered 34 years ago.
Status
Active
Active since incorporation
Company No
02658133
Private limited company
Age
34 years
Incorporated 29 October 1991
Size
Micro
Turnover is under £1M
Under 10 employees
Confirmation
Submitted
Dated 29 December 2024 (10 months ago)
Next confirmation dated 29 December 2025
Due by 12 January 2026 (2 months remaining)
Last change occurred 9 months ago
Accounts
Submitted
For period 1 Apr31 Mar 2024 (1 year)
Accounts type is Small
Next accounts for period 31 March 2025
Due by 31 December 2025 (1 month remaining)
Address
21 & 22 Mayfield Avenue Industrial Park, Fyfield Road
Weyhill
Andover
Hampshire
SP11 8HU
Same address for the past 10 years
Telephone
01264339770
Email
Available in Endole App
People
Officers
3
Shareholders
1
Controllers (PSC)
5
Director • PSC • British • Lives in England • Born in Sep 1982
Director • British • Lives in England • Born in Dec 1946
Mr Feroze Issa Ismail Janmohamed
PSC • British • Lives in England • Born in Jan 1946
Miss Soraya Janmohamed
PSC • British • Lives in England • Born in Mar 1986
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Ridgeway Services Limited
Feroze Issa Ismail Janmohamed is a mutual person.
Active
Imara U.K. Limited
Feroze Issa Ismail Janmohamed is a mutual person.
Active
Wren Laboratories Limited
Feroze Issa Ismail Janmohamed is a mutual person.
Active
Sunbird Investments Limited
Mr Jalal Janmohamed is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
31 Mar 2024
For period 31 Mar31 Mar 2024
Traded for 12 months
Cash in Bank
£838.23K
Decreased by £480.37K (-36%)
Turnover
Unreported
Same as previous period
Employees
3
Same as previous period
Total Assets
£2.27M
Increased by £361.43K (+19%)
Total Liabilities
-£653.76K
Decreased by £23.56K (-3%)
Net Assets
£1.62M
Increased by £384.99K (+31%)
Debt Ratio (%)
29%
Decreased by 6.66% (-19%)
Latest Activity
Mr Feroze Issa Ismail Janmohamed Details Changed
1 Month Ago on 1 Oct 2025
Confirmation Submitted
9 Months Ago on 8 Jan 2025
Small Accounts Submitted
10 Months Ago on 12 Dec 2024
Medipharma Group Limited (PSC) Resigned
1 Year 7 Months Ago on 1 Apr 2024
Wren Laboratories Limited (PSC) Appointed
1 Year 7 Months Ago on 1 Apr 2024
Confirmation Submitted
1 Year 9 Months Ago on 9 Jan 2024
Small Accounts Submitted
1 Year 10 Months Ago on 21 Dec 2023
Small Accounts Submitted
2 Years 7 Months Ago on 24 Mar 2023
Mr Jalal Janmohamed Appointed
2 Years 9 Months Ago on 24 Jan 2023
Confirmation Submitted
2 Years 10 Months Ago on 5 Jan 2023
Get Credit Report
Discover Medipharma Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Director's details changed for Mr Feroze Issa Ismail Janmohamed on 1 October 2025
Submitted on 22 Oct 2025
Confirmation statement made on 29 December 2024 with updates
Submitted on 8 Jan 2025
Accounts for a small company made up to 31 March 2024
Submitted on 12 Dec 2024
Notification of Wren Laboratories Limited as a person with significant control on 1 April 2024
Submitted on 10 Apr 2024
Cessation of Medipharma Group Limited as a person with significant control on 1 April 2024
Submitted on 10 Apr 2024
Confirmation statement made on 29 December 2023 with no updates
Submitted on 9 Jan 2024
Accounts for a small company made up to 31 March 2023
Submitted on 21 Dec 2023
Accounts for a small company made up to 31 March 2022
Submitted on 24 Mar 2023
Appointment of Mr Jalal Janmohamed as a director on 24 January 2023
Submitted on 24 Jan 2023
Confirmation statement made on 29 December 2022 with no updates
Submitted on 5 Jan 2023
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year